The import of heterocyclic compounds with nitrogen hetero-atom only to China is forecasted to grow steadily from $3.77 billion in 2024 to $4.16 billion in 2028. In 2023, these imports stood at approximately $3.68 billion, reflecting a solid upward trend.
The year-on-year growth rate suggests a consistent increase: 2.7% from 2024 to 2025, 2.57% from 2025 to 2026, 2.45% from 2026 to 2027, and 2.36% from 2027 to 2028. Over the five-year forecast period, the compound annual growth rate (CAGR) averages around 2.52%, indicating moderate but steady expansion.
Future trends to watch for:
- Technological advancements driving demand in pharmaceuticals and agriculture.
- Regulatory changes potentially impacting trade dynamics.
- Shifts in global supply chains influencing import reliance and costs.
